EBMT 2019 | Limitations with CAR T-cell therapy in CLL and lymphoma

Tanya Siddiqi

Tanya Siddiqi, MD, from the City of Hope National Medical Center, Duarte, CA, addresses the challenges with CAR T-cell therapy. Dr Siddiqi was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video  
Similar topics